<DOC>
	<DOCNO>NCT00496652</DOCNO>
	<brief_summary>The purpose study determine whether addition fully human EGFr antibody zalutumumab primary curative radiotherapy increase locoregional control Squamous Cell Carcinomas Head Neck .</brief_summary>
	<brief_title>DAHANCA 19 : The Importance EGFr-inhibitor Zalutumumab Outcome After Curative Radiotherapy HNSCC</brief_title>
	<detailed_description>Radiotherapy Squamous Cell Carcinomas Head Neck modify last decade alter fractionation , addition concomitant chemotherapy modification hypoxia . By modification locoregional control , disease-specific survival overall survival increase price increase morbidity . The addition antibodies Epidermal Growth Factor receptor ( EGFR-I ) may increase control survival patient Squamous Cell Carcinomas Head Neck combine radiotherapy and/or chemotherapy . The aim present study determine whether 1 . The addition af EGFr-I zalutumumab increase locoregional control Squamous Cell Carcinomas Head Neck 2 . Whether disease-specific survival overall survival improve addition zalutumumab 3 . Whether addition zalutumumab primary curative radiotherapy chemoradiotherapy feasible tolerable 4 . Acute late toxicity treatment .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Histological proven squamous cell carcinoma pharynx , larynx ( excp . stage 1 larynx stage 1+2 glottic larynx ) Curative intent prior treatment Age &gt; 18 year WHO performance 02 ( incl . ) No prior treatment EGFrI Informed consent accord local guideline national law The patient able ( psychological , sociological , geographical physical ) carry treatment followup Fertile woman must use contraceptive device ( IUD oral contraceptive ) Rhinopharynx carcinomas unknown origin Distal metastases Other malignant disease ( prior current ) except planocellular skin cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Squamous Cell Carcinomas Head Neck</keyword>
	<keyword>Epidermal Growth Factor receptor</keyword>
	<keyword>Antibody</keyword>
	<keyword>Radiotherapy</keyword>
</DOC>